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 Abbreviations 
 
 
MI:                 Myocardial Infarction  
CM:               Cardiomyocyte 
CF:                Cardiac Fibroblast 
EC:                Endothelial Cell 
ECM:             Extracellular Matrix 
EE:                Endocardial Endothelium 
CTE:              Cardiac Tissue Engineering 
SMC:             Smooth Muscle Cells 
Cx43:             Connexin 43 
BrDu:             5-Bromo-2’-deoxyuridine 
μ-TPs:            Microtissue Precursors 
HD-μTPs:       Human Dermal Micro-tissue Precursors 
HDF:               Human Dermal Fibroblasts 
GPMs :           Porous Gelatin Micro-beads  
GAL:              Glyceraldehyde  
PSR:              Picro Sirius Red 
SR:                Sarcoplasmic Reticulum 
NMC:             Non-myocardyal cells  
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Chapter 1 
 
RESEARCH INTRODUCTION, HYPOTHESES AND 
OBJECTIVES 
 
1.1 The Need for Engineered Cardiac Tissue 
Heart disease remains the leading cause of morbidity and mortality in developed 
countries [1]. Thus, there is an urgent demand for more efficacious pharmaceuticals 
to treat heart disease and new methods to repair damaged cardiac tissue. The 
limited ability of cardiac tissue to regenerate [2] and the scarcity of organs for 
transplantation [3] contribute to the need for a larger pool of transplantable cardiac 
tissue. Tissue engineering offers the possibility of creating functional tissue 
equivalents for scientific studies and tissue repair [4]. Representative examples 
include in vitro cultured blood vessels [5], liver [6], kidney [7], muscle [8], bone [9], 
neuronal tissue [10], and cartilage [11]. 
 
1.2 Research Overview and Hypothesis 
Most living tissues are composed of repeating units on the scale of hundreds of 
microns, which are different cell types with well deﬁned three-dimensional (3-D) 
micro-architectures and tissue-speciﬁc, functional properties. To generate thick and 
functional engineered tissues, the recreation of these structural features is of great 
importance in enabling the resulting function [12]. Recent efforts [13,14] have been 
concentrated on bottom-up approaches aimed to generate a larger tissue construct 
by the assembly of smaller building blocks, which mimics the in vivo tissue structure 
of repeating functional units. In this PhD thesis a novel bottom-up approach has been 
applied to produce functional cardiac tissue, starting from the outcomes of recently 
published works [14,15,16].  
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The overarching goal of this work was to create in vitro functional cardiac μ-tissue by 
coupling engineered porous μ-scaffold with neonatal rat cells. We hypothesized that 
such cardiac μ-tissue construct could be used as a functional building unit to obtain a 
3D cardiac tissue in vitro. The μ-scaffolds, consisting of gelatine porous micro-beads 
with a diameters distribution of 75-150 μm, were colonized by cardiac cell population 
in dynamic cell seeding condition by means of spinner flask bioreactor. To optimize 
the micro-tissue functions we varied several culture parameters: spinner culture 
conditions (duration and type of flow regime) as well as the initial composition of 
cardiac cell population. We have successfully established that μ-scaffold construct 
embedded with a specific cardiac cell composition exhibited the important properties 
of native cardiac tissue, including the assembly of differentiated cardiac cell 
populations into a 3D syncytium, as well as electrophysiological functionality and 
responsiveness to external electrical stimulation. Furthermore, it has been tested the 
possibility to produce a 3D cardiac tissue constructs, of defined size and shape, by 
exploiting the biological sintering capability of the micro-tissues (μTPs). We 
conjectured that the cardiac tissue engineered construct developed could be used as 
a biological model for studying cardiac tissue development and/or disease processes 
in vitro, and eventually as an implant to repair injured myocardium. 
 
1.3 Research Objectives 
Overall Objectives 
The overall objective of this project was to create 3D cardiac tissue using cardiac 
μTPs as building blocks. To achieve this we had to 1) devise a method to realize 
cardiac μTPs, 2) to characterize cardiac  μTPs using functional in vitro assays, and 3) 
design a method to achieve a 3D cardiac tissue by assembly the micro-modules that 
act as building blocks for the fabrication of the corresponding macro-tissue. These 
three objectives will be covered in the following section. 
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Specific Objective 1: Fabrication of cardiac μ-TP 
Cardiac μTPs constructs were fabricated using an engineered gelatine porous micro-
bead. The first step was the optimization of cell seeding parameters. In the standard 
conditions [14], HD-μTPs cultivation was initiated by inoculating HDF a density of 10 
cells bead−1, the culture suspension in the spinner flask was stirred intermittently at 
30 rpm (5 min stirring and 30 min static incubation) for the ﬁrst 6h post-inoculation for 
cell adhesion, and then continuously agitated at 30 rpm. In the case of cardiac cell, 
we started the process by inoculating in the spinner flask cardiac cells and gelatin 
porous micro-beads at the ratio of 1000 cells for bead. Compared with previously 
described spinner culture conditions used to generate dermal-like tissue, in the case 
of cardiac cell culture, the ratio between cells and beads must be higher due to lower 
cardiomyocytes proliferation. Moreover, the seeding parameters were slightly 
different because of the difference in the cell adhesion time between dermal 
fibroblasts and cardiomyocytes. Indeed, dermal fibroblasts adhere within 4 hours, 
cardiomyocytes took at least 3 days to adhere and to spread on the substrate. For 
this reason, the spinner culture was carried by using a cycle of 10 minutes at rest and 
30 minutes at 30 rpm for the first 3 days of culture. After this time, the dynamic 
culture switched to continuous stirring at the velocity of 30 rpm up to 9 days of 
culture. Furthermore, we assessed three different cell composition harvested from 
neonatal rat heart with different culture medium in order to promote the realization of 
a μTP  having properties close to native cardiac tissue. Three different experiments 
were performed for the seeding phase; isolated cells were pre-plated onto tissue 
culture polystyrene to reduce the initial non-myocardial cells (NMC) contamination by 
exploiting the differential attachment time between myocardial and non-myocardial 
cells. By pre-plating the whole cell population for one hour it was obtained a cell 
population named cardiomyocite-rich (CM-R). By pre-plating for three step of one 
hour it was obtained a cell population named cardiomyocytes-extra rich (CM-ER). 
The population CM-R will be named along the paper CM-R(+) if used in combination 
with 5-bromo-2deoxyuridine (BrDu) or CM-R(-) it used in absence of BrDu[17]. As 
consequence, different features characterized each formulation of μTP. The choice of 
the first cell population, allowed obtaining a μ-scaffold well colonized by cardiac cells 
and the functional cardiac μTPs. We hypothesized that the presence of BrdU in the 
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culture medium was crucial to maintain a balance between the cardiac cells 
proliferation and the μ-tissue viability.       
 
Specific Objective 2: Characterization of cardiac μ-TP 
The functionalities and morphology of cardiac μ-TP have been characterized during 
culture in order to assess its time evolution. Electrical responsiveness and 
contractility were measured as primary indicators of micro-tissue functionality. We 
investigated the TP self-beating capability along the culture time and verified the 
electrical coupling and electrical synchronization between μ-tissues by means of 
voltage sensitive probes. Furthermore, immunohistological analysis showed that 
connexin43, a gap junction (GJ)-related protein, was detected between μTPs during 
the synchronization and it was assessed a correlation between the connexin 43 
amount in the ECM and μTP electrical activity. In particular higher was the beating 
frequency, higher was the cx43 amount.  In addition, it was showed that the TPs 
were responsive to external electrical stimulation: oscillating electrical field induced a 
synchronous contraction in the TP.  Finally, we studied the capability self-
aggregation of the micro-tissues and the ability of fusion between them in the time. 
 
Specific Objective 3: 3D Cardiac tissue equivalent in vitro 
Cardiac cells were dynamically seeded on micro-scaffold for 3 days in order to 
realize cardiac micro-tissues. The micro-modules realized have been used as 
building blocks for the fabrication of the corresponding macro-tissue. In fact, after 3 
days of seeding, cardiac-μTPs suspension was transferred from the spinner ﬂask to 
the maturation chamber to allow their molding in disc-shaped construct. After 7 days 
of culture we obtained the 3-D cardiac tissue, that showed a macroscopic and 
homogeneously beating distributed throughout on the patch and the histological 
analysis showed similarities with the native tissue. 
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1.4 Thesis Organization 
The thesis is organized into self contained chapters. The first chapter outlines the 
aim of the thesis. While, chapter 2 goes on to review and present the current 
methods and challenges in cardiac tissue engineering as well as relevant 
background literature. In chapter 3 we discuss the fabrication of μTP and their 
behaviour in the time. Finally, chapter 4 focuses on the realization of 3D cardiac 
tissue.  
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Chapter 2 
 
THE HEART, CURRENT METHODS AND CHALLENGES IN 
CARDIAC TISSUE ENGINEERING 
 
2.1 The Heart 
The heart is a muscular organ about the size of a fist, located just behind and slightly 
left of the breastbone. The vertebrate heart is principally composed of cardiac muscle 
and connective tissue; it is an involuntary striated muscle tissue specific to the heart 
and is responsible for the heart's ability to pump blood. The heart pumps blood 
through the network of arteries and veins called the cardiovascular system. The heart 
has four chambers (Fig.1): 
 
 
 
 
 
                                                                        Figure 1: Heart organization 
 
 
•The right atrium receives blood from the veins and pumps it to the right ventricle. 
•The right ventricle receives blood from the right atrium and pumps it to the lungs, 
where it is loaded with oxygen. 
•The left atrium receives oxygenated blood from the lungs and pumps it to the left 
ventricle. 
•The left ventricle (the strongest chamber) pumps oxygen-rich blood to the rest of the 
body. The left ventricle’s vigorous contractions create our blood pressure. 
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The coronary arteries run along the surface of the heart and provide oxygen-rich 
blood to the heart muscle. A web of nerve tissue also runs through the heart, 
conducting the complex signals that govern contraction and relaxation. The heart is 
organized as a complex arrangement of both cellular and acellular components. The 
myocytes are arranged in layers as originally described by Streeter [20] and more 
recently as laminae [21]. These laminae are organized into layers of myocytes two to 
five cells thick and surrounded by an endomysial collagen network. Fibroblasts form 
an interconnected network of cells that lies within the endomysial collagen network 
that surrounds the groups (lamellae) of myocytes [22, 23, 24, 21]. This arrangement 
of fibroblasts in vivo, with interconnected cellular processes forming a network of 
cells within the collagen network, is analogous to the organization of fibroblasts in a 
collagen gel. This in vivo arrangement can allow the fibroblasts to contract the 
endomysial collagen, exerting force on the myocytes. Changes in fibroblast 
contractility have been suggested to impact myocardial relaxation. The distribution of 
endothelial cells and smooth muscle cells is confined to the vasculature. Importantly, 
the intercellular connections of fibroblasts appear to be via at least two different types 
of cell-cell molecules: connexins and cadherins. In mice and rats, the connexins that 
connect fibroblasts to myocytes are connexin43 (Cx43), while connexion 45(Cx45) 
connect myocytes, although the distribution of these connexins may vary in different 
species [23,25]. 
 
2.2 Tissue Engineering in vitro 
There is an increasing demand in regenerative medicine to repair and restore the 
function of injured, degenerated, or congenitally defected tissues. In a wide range of 
pathology, neither native nor purely artificial implantable materials can adequately 
replace or repair these damaged tissues. Tissue self-repair capability is limited to the 
case of bone [6] or skin [7,8] where the damage is not invasive such as a small injury 
or a superficial wound. In many tissues such as myocardium [9] and cartilage [10] or 
in the case of large bone defect and deep skin wound, the self-repairing capability is 
lost and surgery becomes necessary. To overcome such limitations, tissue 
engineering focuses on the in vitro fabrication of living and functional tissue that can 
be implanted in the damaged zone to restore the healthy status. The classical tissue 
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engineering approach (herein referred to as “top-down”) is based on the concept of 
seeding cells into preformed, porous, and biodegradable polymeric scaffolds that act 
as a temporary template for new tissue growth and reorganization (Fig.2).  
 
 
Figure 2: Bottom-up & Top-down approaches to tissue engineering. In the bottom-up approach there are 
multiple methods for creating modular tissues, which are then assembled into engineered tissues with 
specific microarchitectural features. In the top-down approach, cells and biomaterial scaffolds are 
combined and cultured until the cells fill the support structure to create an engineered tissue [4]. 
 
Such cellular construct is then processed in bioreactors that provide a viable 
molecule microenvironment and simulate physiological conditions that furnish 
suitable stimuli for cell survival, differentiation, and extracellular matrix (ECM) 
synthesis [11]. The main drawbacks of this approach are related to: 
 the difficulty in reproducing adequate microenvironmental conditions in a 
three-dimensional (3D) thick structure at the pericellular level;  
 recreating the architecture of native tissue; 
 problems in selecting the ideal biomaterial scaffold for a given cell type;  
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 time constraints in achieving a high enough cell density and the homogeneous 
cell distribution necessary to construct a viable tissue. 
 
By studying the nature of living tissues, it is possible to observe that most of them are 
composed of repeating units on the scale of hundreds of microns, with well-defined 
3D micro-architectures and tissue-specific functional properties. The recreation of 
these structural features is becoming significant in enabling the resulting tissue 
function in vitro [12].  In light of this observation and to overcome the limitation of top-
down tissue engineering, recent efforts have been devoted to bottom-up [13,14] 
approaches aimed at generating a larger tissue construct by assembling smaller 
building blocks (Fig.2) that mimic the in vivo tissue structure of repeating functional 
units. These building blocks can be created in a number of ways, such as self-
assembled cell aggregates [15,14], microfabrication of cell-laden microgel  [12], 
creation of cell sheet [17] and microfabrication of cell seeded micro-beads [18, 19]. 
Once obtained, these building blocks can be assembled in larger tissue through a 
number of methods including random packing, stacking of layers, or direct assembly 
[74]. Templates are rather cheap and allow rapid production of big quantities of 
Microscale Building Blocks of defined shape and size. Their assembly into ordered 
constructs requires further development (Fig. 3).  
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Figure 3: from tissue assembly to tissue development in vitro. Tissue fabrication methods allow the 
assembly of cells into primitive tissue compartments, which are prone to remodeling. The tissue 
geometry along with the manipulation of the environment at a microscale further promotes the self-
organization of cells into more complex tissues in vitro. [4]. 
 
 
Examples of constructs resulting from a bottom-up approach include structures from 
various single cell types and from mixtures of different cell types by pouring different 
types of cell beads into a single PDMS mold (fig 4A). Although approximately 100000 
monodisperse cell beads are required to fabricate millimetrescale 3D tissue. The 
primary advantages of this method are rapid production of millimetre-thick 3D cell 
structures, homogeneous cell density, and tissue formation without necrosis in a 
period of less than a week because of the supply of the cell culture medium through 
cavities between cell beads. In addition, when the millimetre-thick 3D cell structure 
was composed of HepG2 cells and NIH 3T3 cells, albumin secretion increased daily 
from the HepG2 cells in the 3D tissue, but not in the 2D culture system. However, the 
construction of the vessel network in the 3D cell structures is required to maintain cell 
viability over a long period. Adaptations of this method will allow the formation of 
capillary networks in the structure because methods using the mold can integrate 
cell-laden fibers as capillaries into bead-based cell structures [103]. As another 
method of a bead-based assembly, the printing of cellular spheroids or cell-laden 
hydrogel beads can be used to sequentially stack these materials layer-by-layer 
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[104,105]. Combined with computer-aided printing systems, the printing approach 
enables the rapid construction of complex 3D structures with different types of cells.  
 
 
 
Figure 4: 3D organotypic construct (i) Fluorescent image of a macroscopic structure with a complex 
shape. Live cell staining indicates that almost all cells within the structure are alive.( j) 3D cell structures 
formed by knitting cell-laden hydrogel fibers. The fibers are composed of collagen and alginate gel 
encapsulating HeLa cells.34 (k) Ring-shaped cell structure fabricated by printing cell beads. Various cell 
types are spatially coded within the structure.30 (l) Tube-shaped structure prepared by printing cell 
beads.30.[28]. 
 
For example, the printing of cellular spheroids or cell-laden collagen beads has been 
used to reproducibly construct ring-shaped structures containing multiple cell-laden 
beads in specific designed locations (Fig.4B) and hollow tubes (Fig. 4D) 
[104,105,106]. A fiber-based assembly method was recently proposed for the 
construction of 3D cell structures with complex shapes. Assemblies of cell-laden 
hydrogel fibers can be formed by weaving these fibers together, much as threads are 
woven to form cloth [107]. These approaches produce a metastable multicellular 
construct that will remodel over time according to biological and physical principles 
(i.e. migration of the cells, shrinkage of the hydrogel). Shapes and patterns are not 
inevitably translated to the final tissue. Designs must thus focus on promoting proper 
remodeling into the final architecture. Clearly, understanding and promoting tissue 
self organization would tremendously improve tissue microfabrication. The study of 
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the emergence of forms and functions in vitro tissue models is still in its infancy. It is 
likely that those strategies of auto assembly can only reach a limited complexity and 
should be followed by more complex manipulations of the microenvironment. The 
rapid development of complex microfluidic systems, microbioreactors and detecting 
tools allows the long term culture of microscale tissues in precisely defined 
microenvironment. Microbioreactors permit the long term culture in controllable and 
continuous environment using minute amounts of biological factors [107] and to 
include parameters like shear stress, interstitial flow [108,109] or gradients of soluble 
factors [110,111]. They present great possibilities to culture micro-tissues in 
controlled, heterogeneous environments. Mechanisms underlying tissue organization 
such as the development, maintenance of tissues architecture and function are highly 
conserved through organisms and are better understood now than two decades ago 
[112] it appears clearer that, beyond genetic regulation, the tissue architecture and 
microenvironment feeds back to promote its development, maintain its integrity and 
function [113,114]. Thus, to promote in vitro tissue developments, of special interest 
are (i) the creation of multicellular architectures prone to remodeling and (ii) 
strategies and tools to manipulate the microenvironment and promote in vitro 
organization. 
 
2.3 Engineered Cardiac Muscles for Functional Cardiac 
Regeneration  
The heart is one of the most important organs in the entire human body, owes its 
specialized functions to the unique complement of cells and their complex 
arrangements. Its contractile function derives primarily from cardiomyocytes (CMs). 
The myocardium is composed of tightly packed cardiomyocytes connected via gap 
junctions and supported by resident fibroblasts and vascular cell populations, which 
act as supporting cells by maintaining the extracellular matrix (ECM) as well as 
guiding electrical current propagations throughout the heart. Together these three 
cell types form a mechanically and electrically coupled unit that generates the force 
necessary to pump blood throughout the body. Until the recent discovery of resident 
cardiac progenitor cells [1,2] the myocardium was thought to be composed entirely of 
terminally differentiated cells. However, in their native state, these progenitor cells do 
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not contribute sufficiently to the repairing of major cardiac trauma. Regenerative 
potential of the heart is severely limited, predominantly because of a low proliferative 
capacity of CMs and propensity to scar formation following injury. A constant supply 
of oxygen and nutrient is required to sustain the high metabolic demand of CM. For 
this reason, any disruption of circulation to the heart muscle, such as that seen 
during a myocardial infarction (MI), will lead to rapid cell death and tissue necrosis. In 
most cases, the cell debris triggers an inflammatory response that is characterized by 
the infiltration of monocytes and macrophages. The necrotic tissue is then replaced 
by granulation tissue consisting mainly of fibroblasts and collagen. Finally, this tissue 
is remodelled to form a stiff and non-contractile scar tissue. In end-stage heart failure 
and many congenital cardiac anomalies, the requirement for heart transplantation is 
inevitable. While various surgical procedures and pharmacological therapies can 
prolong the life span, neither provides a cure. Heart transplantation results in an 
effective treatment; however, there is a shortage of donor organs. In addition, organ 
rejection and/or failure, life-long requirement for immunosuppression therapy and 
complications of that therapy further threaten the long-term success of heart 
transplants [3]. An alternative cardiac tissue source is required to address a growing 
need. This alternative source of cardiac tissue is most likely to arise from the 
collective efforts of the tissue engineering field, where through a multi-disciplinary 
approach to in vivo and in vitro tissue development, new organs may be generated 
for transplantation and tissues for reconstruction. The National Science Foundation 
(USA) defined tissue engineering as, ‘an interdisciplinary field that applies the 
principles of engineering and the life sciences towards the development of biological 
substitutes that restore, maintain or improve tissue function [4]. The final product of 
tissue engineering developed by the scientists and engineers will require to produce 
implantable cardiac tissue in vitro by combining CM and other supporting cell types in 
an appropriate scaffold. The resulting engineered cardiac tissue should possess 
similar mechanical and functional properties as native cardiac tissue. The presence 
of functional cells should have the capability to secrete ECM and growth factors to 
encourage beneficial host remodeling, which will significantly contribute to the long 
term integration of the implant [5]. 
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2.4 Cell Sourcing for Cardiac Tissue Engineering 
Cell sourcing is perhaps the most important consideration when designing tissue 
regeneration strategies. An optimal cell source should be easily obtainable, the 
choice of cell can directly impact on ECM remodeling, the functioning of the 
regenerated tissue and ultimately host response. The cells selected should also be 
matched with suitable scaffolds, culture conditions and delivery methods in order to 
maximize its therapeutic potential. In cardiac tissue engineering, the cells of interest 
are primarily cardiomyocytes, cardiac fibroblasts, and endothelial cells. The following 
sections will outline the features of these cell types and their most common sources. 
 
Cardiomyocytes  
The most impressive feature of the heart is its ability to contract continuously and 
synchronously during a person’s lifespan. Heart muscle cells, called cardiomyocytes 
(CM), are the primary cell type responsible for the generation of contractile force. The 
developmental origin of CM can be traced back to the mesoderm layer of the 
gastrulated embryo [20]. The heart itself is formed by two separate waves of 
myogenesis known as the primary and secondary heart fields. The primary heart field 
originates from the anterior lateral mesoderm and give rise to the left ventricle of the 
mature heart, while the secondary heart field develops into the right ventricle inflow 
and outflow tracks [21]. The secondary heart field also gives rise to some of the non-
myocyte component of the heart including cardiac fibroblast (CF), smooth muscle 
cells (SMC) and endothelial cells (EC). 
Cardiomyocytes share many similarities with skeletal muscle cells; both are striated, 
multinucleated, and excitable cells. In comparison to skeletal muscle cells, CM are 
more resistant to fatigue, contain more mitochondria, and are more adapted to 
aerobic respiration. Nevertheless, perhaps the most distinct anatomical feature of CM 
are the intercalated discs found between adjacent cells. Intercalated discs are areas 
of cell membrane rich in desmosomes and gap junctions. Desmosomes are cadherin 
family transmembrane proteins that are associated with intermediate filaments. 
Through homophilic binding, desmosomes also confer mechanical cell adhesion and 
integrity between CM. On the other hand, intercellular communications are mediated 
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by gap junctions. Transmembrane proteins called connexins form hemi-channels on 
the membranes of adjacent cells. These connexins can align and form a direct 
channel between the cytoplasm of these adjacent cells, allowing membrane 
depolarization to propagate from one cell to the next, thus facilitating action potential 
propagation over the myocardium. The ultimate goal of cell sourcing in tissue 
engineering is to find a cell type that can differentiate into all the necessary cells 
found in an organ in order to recapitulate organogenesis during development. 
Embryonic stem cells (ESC) derived from the inner cell mass of the blastocyst seems 
to be the best choice for tissue engineering. These cells are pluripotent and have 
strong proliferative capacity compared to adult stem cells. However, pluripotency is 
not without its downfalls. Direct injection of undifferentiated ESC can lead to teratoma 
formation [22]. Therefore, the phenotype of ESC and ESC derived cells must be 
carefully regulated. Selective differentiation of ESC have been shown to be a 
promising path towards a steady source of CM [23,24]. Laflamme et al. demonstrated 
that the injection of differentiated human ESC in a rat model maintains cardiac 
phenotypes and continues to proliferate over 4 weeks [25]. In addition, the same 
group has demonstrated the utility of human ES derived CM in tissue engineering 
application by fabricating contractile cardiac constructs [26]. Although ESC derived 
CM improved cardiac function in vivo, their allogeneic nature poses a significant 
obstacle towards clinical application. The recent discovery of induced pluripotent 
stem (iPS) cells derived from adult fibroblast may be the answer for an autologous 
and pluripotent cell source. The Yamanaka group pioneered the technique in 
restoring pluripotency of somatic cells to the same level as ESC by ectopically 
expressing Oct3/4, Sox2, Klf4 and c-Myc [27]. It can be assumed that current 
methods being used to drive ESC toward CM differentiation can similarly be applied 
to iPS cells. Like other stem cells, the in vivo tumorgenicity and immune response 
toward iPS cells will ultimately determine their clinical usefulness. Further studies are 
needed to answer these questions. From a clinical therapy perspective, the ideal CM 
for tissue engineering should retain contractile phenotype indefinitely, cause minimal 
immune response in the host, and participate in functional remodeling by organizing 
into contractile bundles [28]. Much of these criteria can be satisfied by using CM 
differentiated from stem or progenitor cells. Studies in stem cell lineages have 
identified populations of adult stem cells in tissues, such as adipose [29], skin, dental 
pulp [30] and amniotic fluid [31,32], some of which are capable of differentiating into 
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beating CM [33]. However, the most studied population for cardiac regeneration in 
clinical application to date is the bone marrow derived messenchymal stem cells 
(MSC). These cells inhabit the stromal space of bone marrow. They can be obtained 
through direct bone marrow aspiration or from peripheral blood. In both cases, the 
MSC reside as a subpopulation of cells within the mononuclear cell fraction [34]. 
Under the right condition, these MSC can be induced to express cardiomyogenic 
markers [35] and play a cardioprotective role to nearby cardiomyoblasts [36]. In 
clinical studies, intravenous or intramyocardial injections of MSC in acute MI have 
been shown to increase ejection fractions and vascularity around the infarct area 
[37,38]. However, few MSC differentiate into CM lineage and those that are 
committed have little to do with the functional improvements that are observed [39]. 
Therefore, it appears that much of the benefits of MSC in acute MI are derived from 
their cytoprotective and angiogenic roles [40,41]. Although not a viable CM source for 
therapeutic applications, primary rat neonatal ventricular cardiomyocytes have 
served as a useful cell model that has greatly contributed to the understandings of 
CM physiology and development. Structurally, neonatal CM lack a well developed T-
tubule system, the deep invagination of the sarcolemma, found in adult CM [43]. This 
leads to a more heterogeneous cytosolic Ca2+ concentration compared to adult 
myocytes and contributes to its unique excitation-contraction coupling characteristic. 
 
 
Cardiac Fibroblasts  
The cardiac fibroblast (CF) constitutes the bulk of non-myocyte cell population in the 
heart [44]. They are traditionally defined as cells of mesenchymal origin that produce 
interstitial collagen [45,46] and maintain ECM components, including collagen, 
fibronectin, and laminin. Fibroblasts tend to lack a basement membrane and display 
multiple processes or sheet-like extensions. These cells contain an oval nucleus, 
extensive rough endoplasmic reticulum, a prominent Golgi apparatus, and abundant 
cytoplasmic granular material. Unlike cardiomiocytes and endothelial cell, the cardiac 
fibroblast is found natively in the stromal space and lack basement membranes. This 
feature gives CF its unique ability to migrate and populate injury sites, such as a 
myocardial infarct, and quickly restore tissue volume and ECM proteins [47]. In the 
developing fetal heart, CF contributes to ECM rich structure including valves and 
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atrial ventricular walls. As the heart matures, a 3D network of collagen and CF, 
known as the cardiac skeleton, begins to take shape. This network allows CF to exert 
forces on the myocytes, as well as, to respond to external stimuli through 
degradation and synthesis of ECM. These processes help maintain the mechanical 
integrity of the heart through cell-cell and cell-ECM interactions. More importantly, CF 
forms heterotypic gap junctions with neighboring CM or CF, whereby the conductivity 
of these junctions can be modulated by the differential expression and coupling of 
connexins isoforms, including Cx45, Cx43 and Cx40 [48,49]. The cell-cell interaction 
between CF and CM helps to ensure the long range synchronization of myocardium 
contraction. Cardiac fibroblast also plays a pivotal role during cardiac repair. Under 
appropriate stimulation, relatively quiescent fibroblasts can acquire an active 
synthetic, contractile phenotype and express several smooth muscle cell markers not 
typical of fibroblasts [50]. These cells express contractile proteins, are more mobile 
than undifferentiated fibroblasts, can effectively contract collagen gels, and are 
believed to be important for wound closure and structural integrity of healing scars 
[51]. Moreover, myofibroblasts are associated with hypertrophic fibrotic scars in 
various injury models. Apoptosis of the myofibroblast has been shown to be 
associated with the progression of granulomatous tissue to a mature scar. On the 
other hand, failure of apoptosis has been suggested to drive the progression to 
fibrosis.  However, upon injury, myofibroblasts appear in the myocardium and are 
believed to arise from resident interstitial and adventitial fibroblasts. They may also 
originate from progenitor stem cells in the heart or from the circulation. Whatever 
their origin, the dynamic balance between fibroblast and myofibroblast phenotype is a 
critical factor in the wound healing outcome. 
 
Cardiac Endothelial Cells 
The complex cavitary surface of the cardiac wall is completely lined by the 
endocardial endothelium (EE). The morphology of the EE has been well described 
[42]. It is recognizable as a sheet of endothelial cells with a central nuclear bulge and 
distinct, extensive intercellular junctions. EE cells are somewhat larger than 
endothelial cells in most other portions of the circulatory system. The luminal surface 
of most of these cells possesses a scattered variety of microappendages, or 
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microvilli, projecting into the cardiac cavity. It can be estimated that the labyrinth of 
trabeculae and furrows, together with the numerous microvilli on the luminal surface 
of the EE cells, may augment the surface area by a factor of 100 or more. This 
surprisingly large contact surface area of the EE offers an astonishingly high ratio of 
cavitary surface area to ventricular volume, particularly in the right ventricle. This 
suggests an important sensor role for the EE [75]. One of the key factors for 
myocardial regeneration is revascularization of damaged tissue. In the normal heart, 
there is a capillary next to almost every CM, and endothelial cells (ECs) outnumber 
cardiomyocytes by 3:1 [76]. Developmental biology experiments reveal that 
myocardial cell maturation and function depend on the presence of endocardial 
endothelium at an early stage [76]. Experiments with inactivation or overexpression 
of vascular endothelial growth factor (VEGF) demonstrated that at later stages, either 
an excess or a deficit in blood vessel formation results in lethality due to cardiac 
dysfunction [76,77]. Both endocardium and myocardial capillaries have been shown 
to modulate cardiac performance, rhythmicity, and growth [78]. In addition, a recent 
study showed the critical importance of CM-derived VEGF in paracrine regulation of 
cardiac morphogenesis [79]. These findings and others highlight the significance of 
interactions between CMs and endothelium for normal cardiac function. However, 
little is known about the specific mechanisms for these interactions, as well as the 
role of a complex, 3-dimensional organization of myocytes, ECs, and fibroblasts in 
the maintenance of healthy cardiac muscle. The critical relation of CMs and the 
microvasculature suggests that successful cardiac regeneration will require a 
strategy that promotes survival of both ECs and CMs. 
 
2.5 Properties and Functions of Cardiac Extracellular     
Matrix 
The cardiac ECM is composed mainly of collagen and plays a vital role in myocardial 
structure and function. It serves to direct contractile force generated by cardiac 
myocytes and contributes to the passive stretch characteristics of the ventricle. Thus 
deformation of the extracellular matrix may help restore ventricular myocytes to 
precontraction length [52,53]. This expansion phase is thought to create suction that 
pulls blood into the ventricles from the atria. Collagen subtypes and fibronectin 
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compose the majority of cardiac ECM proteins. The majority of ECM components in 
the heart are secreted by cardiofibroblasts and myofibroblasts [53,54,55]. Cardiac 
myocytes and cells of many organs adhere to the extracellular matrix via matrix-
specific receptors including those for fibronectin [56]. Moreover, these ECM 
components are able to transmit external stimuli to the myocytes and fibroblast and 
trigger intracellular signaling that can alter cellularfunctions. Recent work by Ott et al. 
demonstrated that decellularized native cardiac tissue can be repopulated with CM 
and CF and give rise to functional tissue that possesses the microarchitecture of 
native tissue [57]. This suggests that both the composition and organization of ECM 
molecules are important for proper tissue development. Collagen types I and III are 
the most abundant forms of collagen within the myocardium [58,59], and cornprise 
the bulk of replacement scar tissue following myocardial infarction [60]. The cardiac 
ECM is a complex array of different molecular components, and that it plays an 
important role for the transfer of mechanical force in both contraction and relaxation 
phases in the cardiac cycle. As impaired lusitropic cardiac performance may 
contribute to the overall pathogenesis of heart failure, investigations of the regulation 
of cardiac ECM component gene transcription and ECM protein deposition in various 
disease states and growth are essential. 
 
Collagen 
Collagen type I is the major collagenous product of cardiac fibroblasts as this 
molecular species represents about 80% of the total cardiac collagen content [59, 
62]. This observation is in agreement with the results of a recent study of collagen 
isoforms synthesized by cultured cardiac fibroblasts [63]. Two different collagen 
subunits, the products of a unique gene, coalesce to form the trimeric protein. Two 
thirds of the trimer is formed by two α-1 (I) chains (molecular weight = 95 kDa); the 
remainder of the trimer is an α-2 (1) chain (95 kDa). Procollagen polypeptides 
undergo cleavage before becoming mature cellular proteins wherein peptide 
sequences are removed from both the amino and carboxyl ends by specific 
proteases. Collagen type I is characterized by a unique lack of disulfide bonds 
between adjacent chains. Collagen type III is relatively abundant in the myocardium, 
accounting for approximately 12% of myocardial collagen content. Collagen type III, 
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composed of three identical chains of α-1 (III) subunit polypeptides, forms aggregates 
(struts) which are thinner than those containing collagen type I in heart. The 
procollagen a-1 (III) subunits have a molecular weight of 140 kDa which is reduced to 
95 kDa after posttranslational modification. Jointly, collagen types I and III represent 
more than 90 % of all myocardial collagen. 
 
2.6 Biomaterials for Cardiac Tissue Engineering  
Scaffolds may be formed from natural, synthetic or hybrid materials and fashioned to 
provide appropriate pore size, connectivity and strength, adhesion, or even to furnish 
growth factors ‘on demand’ by incorporating these into surface coatings, in so called 
‘smart surfaces’. The traditional paradigm of tissue engineering is to seed-shaped 
scaffolds with cells ex vivo and implants the composite structure into the living 
animal, where the tissue is vascularized and the scaffold incorporated into 
surrounding tissues or progressively replaced by the host tissue [4]. Scaffold used in 
cardiac tissue engineering must reflect the natural cardiac scaffold and will depend 
on the type of construct desired. For example, scaffolds used to develop a graft 
overlaying an infarct site may require different elasticity characteristics to a 
composite tissue used to replace a full-thickness myocardium, which is subjected to 
full systolic pressure. Material tested for cardiac tissue engineering include 
polyurethrane [65], 1,3-trimethylene carbonate [66] and D,L-lactide and copolymers, 
poly(1-caprolactone) [67], polyglycolic acid (PGA), poly(lactic acid) (PLA) and 
polyglycolic acid [68]. While CM growth has been reported on these polymers, 
significant problems associated with the elastic properties of polymeric materials 
(inability to stretch synchronously with native heart), acidic (PGA, PLA) or toxic (PU) 
degradation products remain to be resolved before these products can be fully 
utilized in cardiac tissue engineering. While some natural materials such as gelatine 
[69] and alginate [70,71] can be incorporated into three-dimensional structures in 
order to encourage better cell interaction with the scaffold, other materials, such as 
collagen I and Matrigel, are most similar to mammalian cellular ECM-like 
environments and most supportive of implanted CM survival by facilitating cell 
adhesion, proliferation and differentiation. However, because of their rapid 
degradation by local tissue proteases, the potential immunogenicity and as a 
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potential reservoir of infectious agents [72] these natural materials are currently being 
modified and are more often used in conjunction with solid scaffolds [73]. Other 
technologies for cardiac tissue engineering are being developed in very creative 
ways, such as using mechanical strain to condition tissue [81] or decellularization of 
a rat heart as a natural scaffold [57]. New technologies that generate scaffold-less 
cell dense CM sheets have also been reported and have shown potential in vivo. 
More importantly, this technology bypasses the issues associated with the use of 
exogenously added natural and synthesized scaffold [80]. 
 
2.7 Bioreactors 
The 3D cell constructs that are development ex vivo usually lack the vascular 
network that exists in normal vascularised tissue. Thus, the gas and nutrient supply 
to the scaffold-seeded cells depends merely on mass diffusion. In static cultivation, 
with no fluid mixing, large diffusion gradient are performed between the cell 
constructs and their surroundings so that the cells in the centre of the construct do 
not get sufficient nutrients; the waste removal from the centre is poor; and thus the 
cells eventually die. Oxygen transport is typically considered as the main limiting 
factor for nutrient exchange [91]. To improve mass transport, researchers have 
designed several bioreactors, which exemplify different patterns of fluid dynamics 
and vessel geometry. A basic fluid-dynamic cultivation vessel is the spinner flask, 
which is a flask usually agitated at 50 rpm [92,93]. In these vessels, the cells 
constructs are subjected to turbulently mixed fluid that provides a well-mixed 
environment around the cell constructs and minimized the stagnant layer at their 
surface. It has been shown that cultivation of cardiac cell constructs in spinner flasks 
produces engineered tissues that are superior, in almost every aspect (aerobic cell 
metabolism, metabolic activity, morphological appearance, etc.) to tissues cultivated 
under static condition [92,93,94]. Bioreactors combined with mechanical signal 
stimuli improved the proliferation and distribution of the seeded cardiac cell 
throughout the scaffold volume and further stimulated the formation and organization 
of ECM, which contributed to the improvement in the mechanical strength of the 
cardiac graft [61,95]. Future bioreactors for CTE should combined both perfusion and 
mechanical stimuli; for example, by allowing for adjustable pulsate flow and varying 
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levels of pressure. Such bioreactors are currently under development for engineering 
heart valves ex vivo [96,97]. One of the most important difficulties in CTE is to grow 
3D structures that contain more than a few layers of muscle cells. Most bioreactors 
simply cannot supply enough nutrients and oxygen to the growing tissue. Whereas 
human heart muscle is approximately 100 micrometers, or less than 10 cell layers, 
thick. Beyond this thickness, the innermost cells are too far from the supply of fresh 
growth medium to thrive. After transplantation, rapid vascularisation, adequate 
perfusion, survival, integration, and function of the engineered cardiac patch remain 
critical steps in the translation of in vivo achievements into an effective therapeutic 
tool [98]. 
 
2.8 Fabrication and Culture Platforms for Cardiac Tissue 
Engineering 
One of the key challenges is certainly the choice and the interaction between cells 
and biomaterials on a molecular level to contribute to the functionality of the 
engineered tissue. To maximize the regenerative potential of the cells, one must 
consider the impact of tissue fabrication and culture strategies on the cells’ 
behaviour. Schematic diagrams of these cardiac tissue engineering strategies can be 
found in figure 5 [90]. The classical tissue engineering approach is the creation of a 
tissue construct by seeding desired cells into a scaffold in vitro with or without 
manipulation (e.g. special conditioned culture system [82]) followed by implantation in 
vivo. The disadvantage of this method is that poor survival of implanted cells; also 
these can only be seeded on the surface and must actively migrate into the core of 
the scaffolds. This may lead to uneven cell seeding throughout the depth of the 
scaffold.  The said observations indicate that cell survival in the construct is one of 
the major obstacles to engraftment of engineered constructs in vivo. To improve cell 
survival, several strategies have been investigated including the use of various cell-
supporting scaffold materials [67,68]. Incorporation of pro-angiogenic factors and pro-
survival factors into scaffolds [73,64] co-culturing of CMs with other cell types to form 
vasculature [83,84] in vitro or a combination of these strategies, with some success 
in improving engrafted cell survival. 
26 
 
 
Fig. 5: Diagram showing the main strategies used in cardiac tissue engineering: (a) the ‘classical’ tissue 
engineering approach with cells seeded into scaffold then implanted in vivo; (b) engineered heart tissue 
(EHT) approach; (c) cell sheet approach; (d) gravity enforced cell assembly approach; and (e) 
decellularized heart scaffold approach [90]. 
 
One way to improve the uniformity of seeding cells within the scaffold is to combine 
cells with compatible hydrogel prior to casting and gelation. One of the most creative 
and promising approaches to cardiac tissue engineering  uses neonatal rat CMs, 
collagen I matrix, Matrigel and a mechanical stretching device to create a 
spontaneously contractile construct called engineered heart tissue (EHT) [9,81,85]. 
Nonetheless, cells embedded near the core of the gel still suffer from diffusion 
limitation and tend to have low viability. Therefore, recent studies have shifted their 
focus towards the fabrications of micro-tissue such as the approach described within 
this thesis. By shrinking the size of the scaffold down to several hundred micrometers 
in diameter, cells embedded in the core may receive sufficient nutrients to survive.  
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Instead of seeding cells into a three-dimensional porous scaffold, Kelm et al. have 
created micro-tissues (~100 μm) containing CM capable of supporting core tissue 
viability, in fact provide an environment for them to migrate and assemble into 
contractile tissues  in vitro using gravity-enforced techniques to form spheroid-like 
micro-tissues [14,86]. Another CTE approach that holds clinical application potential 
is the cell sheet technique [87]. The centerpiece of this approach is the invention of a 
thermo-sensitive cell culture surface, coated with a polymer – poly (N-
isopropylacrylamide, PIPAAm), which is cell adhesive at 37°C and changes its 
properties in reverse below 32°C. Once CMs have aggregated and formed gap 
junctions, changing the temperature allows the beating cells to be lifted off the culture 
dish as a cell sheet without disruption to their gap junctions or architecture [88]. 
Further in vivo work demonstrated the potential for stacking individual CM cell sheets 
into a three-dimensional contractile cardiac tissue [80], which survived subcutaneous 
implantation for 1 year and application to rat hearts showed functional integration of 
the cell sheet with the host heart [89]. The benefit of this approach is a scaffold-free, 
cell dense tissue similar to compact myocardium. This approach, however, is limited 
by the diffusion of nutrients to sustain the viability of the patch and remains to be 
adapted for formation of thick myocardial tissue constructs where specific 
vascularization strategies will need to be employed. 
 
2.9 Biomaterials for cell delivery into the heart 
The past decade’s burst in cell therapy clinical trials has resulted in a multitude of 
reports ranging from high expectations to modest questioning of the efficacy of cell 
therapy for cardiovascular disease. The perception is, however, that cell therapy 
would greatly benefit from improvements in the techniques of cell delivery and an 
improved understanding of mechanisms driving heart repair. A lack of 
standardization across clinical trials, because of variable cell sources and 
preparations, delivery methods, target patient population, time points, and functional 
readouts, has only added to the inherent variability, making a comprehensive cross 
study comparison rather difficult. To move forward, we need to develop new 
technologies that can address the challenges and limitations of the current preclinical 
trials. Cell injection: The administration of cell suspensions in fluid via a syringe or 
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catheter results in massive attrition after injection, by processes that occur almost 
immediately, and irrespective of cell type or formulation, delivery mode, and disease 
state. These processes occur before the vascular supply can be established and 
integration with the host cells can occur. The capacity of the heart to retain implanted 
cells for even 24 h is rather small [99], and local barriers of cell survival and function 
beyond this time point are substantial. Survival of ‘‘naked’’ cells in the hostile 
environment of an acute or chronic infarct is a major challenge. Several possibilities 
have been identified for improving cell engraftment and maximizing the potential of 
cells to mediate heart regeneration. One reported approach identified the addition of 
prosurvival factors into the cell suspension as a method to substantially improve the 
survival of transplanted cardiomyocytes [100]. A solution for improved cell retention, 
just starting to be explored in the lab settings, is the use of catheter-based hydrogel 
cell delivery, which builds on existing delivery methods used in the clinic. Hydrogels, 
delivered as a fluid phase suspension via catheter, slowly polymerize during the 
trajectory to the target tissue, polymerizing and entrapping cells in situ. With already 
extensive use and demonstrated safety of catheter-based cell delivery [101], the 
addition of a delivery vehicle offers a possibility for improving engraftment. Hydrogels 
offer additional distinct advantages of customization using growth factors to 
specifically enhance the vasculogenic or myogenic capacity of encapsulated cells 
[102], while physically shielding cells from the harsh ischemic environment, as they 
mediate repair. Although this option provides for a near-term solution to improve cell 
retention in the heart, it can be further advanced to mediate the effects of the 
microenvironment in situ. 
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Chapter 3 
 
A BOTTOM-UP APPROACH TO CARDIAC TISSUE 
ENGINEERING: HOW TO BUILD-UP A TISSUE 
EQUIVALENT IN VITRO 
 
Bottom up strategy  
In this study, we exploited a bottom-up approach to build a functional cardiac μTPs in 
vitro. Initially, we focused on generating μ-sized tissue modules with specific 
microarchitectural features that can be used alone as living fillers in damaged areas 
or serve as building blocks to engineer large biological tissues through a bottom-up 
approach. The process philosophy is schematized in figure 1. The optimized dynamic 
culture conditions used, coupled with the sub-millimetric nature of the μTP, allowed to 
overcome the transport limitations and enabled the massive production of viable and 
functional micrometric building blocks. Moreover, we devoted particular attention to 
the role of micro-scaffolds in addressing μ-tissue reorganization. Indeed, despite 
many works regarding scaffold free tissue regeneration [19,20,22], we demonstrated 
that micro-scaffolds are crucial in the early stages of the culture because they 
triggers the cell to synthesize precursors of ECM that act as a natural surrounding 
environment for cardiac cells. In this work, we observed that the scaffold does not 
hinder the electromechanical properties of the cardiac μ-modules, which showed 
spontaneous beating and synchronization properties. This suggests that the cardiac 
μ-TP as an implantable living micro-tissue for infracted zone regeneration or can be 
used as representative tissue modules for TOC applications. 
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Figure 1: Scheme of the bottom-up process 
 
 
3.1 Introduction  
The heart is the first organ formed in the embryo and all subsequent activities in life 
depend on its functioning. The past decade has witnessed decisive advances in 
understanding cardiac functions and dysfunctions, both a genetical and molecular 
level. Although such insights into the mechanisms of heart development and disease 
have stimulated new therapeutic opportunities for the prevention and palliation of 
cardiac pathogenesis, mortality rates associated with heart related pathologies 
remain at the top of disease statistics in industrialized countries [10]. Since cardiac 
myocytes lose their ability to divide after birth, the regenerative capacity of adult heart 
tissue is limited and substantial cell loss or dysfunction, such as what occurs during 
myocardial infarction, is largely irreversible and may lead to progressive heart failure 
[11]. Recently, cell transplantation to repair or supplement impaired heart tissue has 
been pursued by various approaches as an alternative therapy for heart 
transplantation [12]. Several possible cell types, including myoblasts, cardiomyogenic 
cells derived from bone marrow stroma, Lin- c-kitpos bone marrow cells, multipotent 
endothelial cells, and embryonic stem cells, have been reported as human 
implantable cell sources [13,14]. Myocardial injection of autologous myoblasts has 
been clinically performed and shown to produce some limited recovery from heart 
dysfunction [15]. In these therapies using direct delivery of isolated cells, each cell 
differentiates and remodels in response to its surrounding environment, leading to 
tissue regeneration and functional repair. In contrast to isolated cells, research on 
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further advanced therapies to transplant tissue-engineered functional heart grafts has 
also now begun [16]. As originally proposed by Langer and Vacanti [17] the most 
popular in tissue engineering approach is based on the premise that preparations of 
cells, extracellular matrix (ECM), and growth factors together lead to tissue 
reconstruction, and that 3-dimensional (3-D) biodegradable scaffolds are useful as 
alternatives for ECM. The scaffold temporarily provides the biomechanical support for 
the cells until they produce their own extracellular matrix. Because tissue-engineering 
constructs contain living cells, they may have the potential for growth and cellular 
self-repair and remodelling. This context has also been applied to cardiac tissue 
engineering. A crucial factor in creating viable 3-dimensional tissue in vitro is the 
achievement of adequate perfusion throughout the tissue. This is especially true for 
cardiac tissue due to its high metabolic rate and oxygen demand. Radisic et al. [18] 
incorporated oxygen carriers and flow channels into neonatal rat cardiomyocyte 
seeded scaffolds to overcome the transport limitations. A 3-dimensional model was 
used by Zimmermann et al. [19], where a neonatal ventricles rat cell population was 
embedded into a Matrigel/collagen gel. Other 3-dimensional culture systems rely on 
cell secreted extracellular matrix (ECM) as the major matrix component [23]. Other 
techniques for the recreation of cardiac muscle in vitro are based on the creation of 
cardiac micro-muscle that can be used alone or serve a building block for the 
creation of macroscopic tissue. Kelm et al. [20, 21] created tissue spheroids 
containing CM in a hanging drop culture system. The scale of these micro-tissues 
(~100 μm) has been shown to support core tissue viability. Sefton et al. made cardiac 
micro-modules by cell laden technology where cardiac cells were embedded in 
biopolymer micro-modules. Cardiac cells were able to survive and to respond to 
external stimuli, but they could neither self-beat nor self-aggregate into superior 
scales. Finally cardiac muscle can also be fabricated by means of cell sheet 
technology. Shinizu et al. [22] demonstrated that sheets of cardiac cells can be 
harvested as an intact micrometric layer and stacked with other cardiac sheets to 
obtain a macroscopic tissue of about a hundred of microns. In the works discussed 
so far there is a lack of information regarding the possibility of recreating a cardiac 
surrogate in vitro ensuring that cardiomyocytes are embedded in their own ECM. 
Indeed, even if such micro-tissues possessed many of the functions of cardiac 
muscle at micron scale they were composed mainly by cell aggregates. We argue 
that the presence of an endogenous ECM plays a relevant role for the tissue 
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engineered constructs. Cell / ECM cross-talk is a key-factor in the native tissue and 
should be maintained in vitro. This leads to the creation of more representative tissue 
models improving the performance of both in vitro, such tissue on a chip system 
(TOC), and in vivo applications.  
 
3.2 Materials and Methods  
3.2.1 Micro-scaffold production 
Preparation of gelatin porous micro-beads 
Gelatin porous micro-beads (GPMs) have been prepared according to a modified 
double emulsion technique (O/W/O) [1]. Gelatin (type B Sigma Aldrich Chemical 
Company, Bloom 225, Mw=l 76654 Dalton) was dissolved into 10 ml of water 
containing TWEEN 85 (6% w/v) (Sigma Aldrich Chemical Company). The solution 
was kept at 60°C. Toluene containing SPAN 85 (3% w/v) (Sigma Aldrich Chemical 
Company) was continuously added to the aqueous gelatin solution (8 % w/v) to 
obtain primary oil in water emulsion. The added toluene formed droplets in the gelatin 
solution until saturation. Beads of gelatin containing droplets of toluene were 
produced through the addition of excess toluene (30 ml). The overload of toluene 
allowed the obtaining of a double emulsion (O/W/O). After cooling below 5°C, 20 ml 
of ethanol was added to extract toluene and stabilize GPMs. The resulting 
microspheres were filtered and washed with acetone and then dried at room 
temperature. Microspheres were separated selectively by using commercial sieves 
(Sieves IG/3-EXP, Retsch, Germany). GPMs with 75-150 μm size range were 
recovered and further processed. After sieving the number of micro-carriers per 
milligram was determined by counting micro-beads in cell culture dish (w/2 mm grid 
Nunc). Finally the micro-beads morphology has been examined by means of 
Scanning Electron Microscopy (SEM). 
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Crosslinking of GPM 
Crosslinking of GPMs have been stabilized by means of chemical treatment with 
glyceraldehyde (GAL), in order to make them stable in aqueous environment at body 
temperature. In particular, GPMs were dispersed into acetone/water solution 
containing GAL and mixed at 4°C for 24 h. Then microspheres were filtered and 
washed with acetone and dried at room temperature. The percentage of the 
crosslinking agent (GAL) introduced during the stabilization step was 2% and 5% w/w 
(GAL / micro-beads).      
 
Scanning electron microscopy (SEM) 
SEM was performed to analyze the morphology of naked micro-beads. The former 
didn’t need any dehydratation process so micro-beads were mounted onto metal 
stubs using double-sided adhesive tape and then gold-coated using a sputter coater 
at 15 mA for 20 min. Coated samples were then examined by scanning electron 
microscopy (FE-SEM, Ultraplus Zeiss).      
 
3.2.2 Cardiomyocyte isolation 
Hearts were removed aseptically from neonatal (2–3 days old) Wistar rats 
immediately after euthanasia with CO2. The atria were removed and the ventricles 
placed in cold CBFHH buffer(NaCl 58.44g/mol, KCl 74.56g/mol, MgSO4x2H2O 
246.48 g/mol, KH2PO4 136.09 g/mol, Na2HPO4x2H2O 177.99 g/mol, Glucose 
dehydrated 180.16 g/mol, HEPES 238.3 g/mol, PH 7.4) containing antibiotics 
[streptomycin and penicillin (50 U/ml; GIBCO BRL, Carlsbad CA); ampicillin (100 
mg/ml; Sigma, St. Louis, MO)] and antimycotic amphotericin B (5 _g/ml; Mediatech, 
Herndon, VA). The ventricles were rinsed in CBFHH three times to remove leftover 
blood and minced into pieces<1mm3. Then the ventricles were dissociated into single 
cells by proteolytic enzymes during repeated digestions with gentle stirring. 
Pre-digestion 
 Add 8ml of Collagenase (180U/ml Collagenase type II Worthington co#CLS-2) 
solution to the tissue. 
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 Digest for 10 min on the shaker to 37°C. 
 Let tissue sediment and discard supernatant. 
 Digestion cycles 
 Add 8ml of Collagenase solution to the tissue. 
 Digest for 10 min on the shaker to 37°C. 
 Let tissue sediment and transfer supernatant to the first “tube collection” (The 
enzyme solution containing the digested tissue was neutralized with an equal volume 
of culture medium (DMEM, 1g/l Glucose), supplemented with 10% fetal bovine 
serum, 1% penicillin (100U/mL) and streptomycin (100 mg/mL). 
 Add 7ml of DNase solution (4μg/ml DNase I, type V from bovine spleen, 
Sigma co#D8764) to the tissue. 
 Pipette up and down for 20 to 25 times to ensure adequate mixing. 
 Let sediment deposit again and transfer the supernatant to same “collection 
tube”. 
 Start again by adding collagenase solution and follow the same cycle only 
changing in the time the amount of solution and the digestion time until the tissue has 
completely been dissolved. 
The cell suspension in the collection tubes was sifted by the sieve (pore size 100μm) 
with 10-15 ml of culture medium and then centrifuged at 1200 rpm for 15 min at 4°C. 
Isolated cells were pre-plated onto tissue culture polystyrene to reduce the initial non-
myocardial cells (NMC) contamination by exploiting the differential attachment time 
between myocardial and non-myocardial cells. By pre-plating the whole cell 
population for one hour it was obtained a cell population named cardiomyocite-rich 
(CM-R). By pre-plating for three step of one hour it was obtained a cell population 
named cardiomyocytes-extra rich (CM-ER). The population CM-R will be named 
along the paper CM-R(+) if used in combination with 5-bromo-2deoxyuridine (BrDu) 
or CM-R(-) it used in absence of BrDu.  
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3.2.3 Micro-tissue realization and characterization 
Process overview 
The realization of cardiac micro-tissues (c-μTPs) consists of a dynamic cell culture on 
gelatin porous microspheres. The whole process is divided in three phases: the 
seeding phase (SP, duration three days) and evolution phase (EP, duration nine 
days) allow cell attachment and micro-tissue maturation in the spinner flask 
bioreactor; the aggregation phase (AP, duration seven days) allows micro-tissue bio-
fusion and building-up of the macroscopic tissue in a maturation chamber kept under 
dynamic culture conditions.  
 
Seeding Phase (SP)  
Dry GPM were sterilized before using by absolute ethanol sub-immersion for 24h. 
Successively several washings in calcium-free and magnesium-free phosphate-
buffered saline (PBS) were performed to remove completely the ethanol. Before cell 
seeding PBS was removed and replaced with the culture medium. Cardiac-μTPs 
cultivation was initiated by inoculating CM-R and gelatin porous micro-spheres at a 
ratio of 1000 cells*bead−1 in a spinner flask bioreactor (Integra Bioscience, cod#182 
023) filled with 150 ml of culture medium (DMEM, 1g/l Glucose supplemented with 
10% foetal bovine serum, 1% penicillin 100U/mL and streptomycin 100 mg/mL) and 
inserted in an incubator with controlled atmosphere (37°C in humidified atmosphere 
containing 5% CO2). To optimize the seeding parameters, the spinners were 
operated up to three days under two different conditions: a) 5 min stirring at 30 rpm 
and 30 min resting for six h followed by continuous stirring at 30 rpm up to three 
days; b) 5 min stirring at 30 rpm and 30 min resting up for three days.              
                                                                                                                                    
MTT assay 
Aliquots containing micro-tissues at S3 were collected from the spinner operating 
under conditions (a) and (b) and, transferred in a Petri dish, then 900μl of culture 
medium and 100μl of MTT (3-(4, 5_dimethyltiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide - Sigma) solution were added. The MTT assay is a colorimetric assay for 
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assessing cell viability. Enzyme-based methods using MTT rely on a reductive 
coloring reagent and dehydrogenase in a viable cell to determine cell viability with a 
colorimetric method. This method was easy-to-use, safe, has a high reproducibility, 
and was widely used in both cell viability and cytotoxicity tests.  Among the enzyme-
based assays, the MTT assay was the best known method for determining 
mitochondrial dehydrogenase activities in the living cells. MTT was reduced to a 
purple formazan by NADH. After incubation for 45 min at 37°C the micro-tissues 
were observed and imaged under optical microscope (BX53; Olympus). 
 
Evolution Phase (EP) 
The realization of the micro-tissues was carried out by using CM-R (-), CM-R (+) and 
CM-ER cells in different experiments. For all spinner culture conditions the seeding 
phase was performed under intermittent stirring (5 min stirring at 30 rpm and 30 min 
resting up to three days – corresponding to SP condition (b), see seeding phase). 
After the SP phase, the dynamic conditions were switched from intermittent to 
continuous stirring at 30 rpm to allow μTP evolution (EP phase) for a total duration of 
nine days. In the experiments with CM-R(+), culture medium encircled with BrDu 0.2 
mM was used from the third day till the ninth day. The culture medium was changed 
every two days. Aliquots of 5 ml of culture medium containing micro-tissues were 
collected for subsequent analyses at two time intervals: short time, ranging from 3 - 5 
days (EP3 - EP5); long time, ranging from 6 – 9 days (EP6 - EP9).   
 
Alamar Blue assay 
After the seeding phase, three aliquots from spinner flasks containing CM-R (-) and 
three aliquots from CM-R (+) were collected into cell culture dish (w/2 mm grid Nunc) 
for μ-TP counting and after was transferred in multiwell low attachment (Corning 
Costar Ultra-Low Attachment Multiwell Plates 24 well). The multiwell containing μ-
TPs was kept in incubator under continuous stirring at 30 rpm to recapitulate the 
spinner flask conditions. At time point corresponding to EP1, EP3, EP5, EP7, EP9, 
EP11, the μ-TPs were incubated for 4 h at 37°C in humidified atmosphere containing 
5% CO2 with Alamar Blue (Invitrogen) and the number of cells as indicated by the 
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was evaluated by spectrophotometric reading as indicated by the manufacturer . It 
was thus possible to have an index of the number of cells per micro-beads during the 
culture time. Alamar Blue is a proven cell viability indicator that uses the natural 
reducing power of living cells to convert resazurin to the resorufin. The active 
ingredient of Alamar Blue (resazurin) was a nontoxic, cell permeable compound that 
was blue in colour. Upon entering cells, resazurin was reduced to resorufin. Viable 
cells continuously converted resazurin to resorufin, thereby generating a quantitative 
measure of viability cellular. After incubation with Alamar Blue, the samples can 
readily be measured on spectrophotometer (on a UV-Vis at 570 nm and 595nm).  
Finally, results were analyzed by plotting absorbance intensity vs compound 
concentration. 
 
3.3.4 Cell viability and morphology on the micro-beads 
Histology 
Over culture time (EP1 to EP9) 1 ml of μTP suspension was collected from the 
spinner culture every two days and ﬁxed in a solution of 10% neutral buffered 
formaline for 24 h, dehydrated in an incremental series of alcohol (75%, 85%, 95% 
and 100%, and 100% again, each step 20 min at room temperature) treated with 
xylene and then embedded in paraffin. Successively, the samples were sectioned at 
a thickness of 7µm, and stained using hematoxylin-eosin (Bio Optica) solutions and 
Picro Sirius Red (PSR) (Sigma Aldrich) following standard procedure, finally the 
sections were mounted with Histomount Mounting Solution (invitrogen) on coverslips 
and the morphological features of constructs were observed with a light microscope 
(Olympus, BX53). Moreover, histological sections stained with PSR were further 
observed by using polarized microscope. Polarized light images of samples stained 
with PSR alone were acquired with an inverted microscope (BX53; Olympus) with a 
digital camera (Olympus DP 21). A linear polarizer was placed between the light 
source and the specimen, while the analyzer was installed in the light path between 
the specimen and the camera. It is known that the colour of collagen fibers stained 
with PSR and viewed with polarized light depends upon fiber thickness; as fiber 
thickness increases, the colour changes from green to r 
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ECM composition 
To quantitatively determine the proportion of different colored collagen fibers, we 
resolved each image into its hue, saturation and value (HSV) components by 
applying the software’s “color threshold” function. Only the hue component was 
retained and a histogram of hue frequency was obtained from the resolved 8-bit hue 
images, which contain 256 colors. We used the following hue definitions; red 0-51, 
green 52-120 [4,5]. The number of pixels within each hue range was determined and 
expressed as a percentage of the total number of collagen pixels, which in turn was 
expressed as a percentage of the total number of pixels in the image. The analysis 
was performed on 10 Picro Sirius Red stained sections of each time points and 
different region of interests (ROIs) were examined for each section. Since the aim of 
imaging analysis was to investigate the evolution of endogenous ECM composition, it 
was necessary to exclude by ROI the areas occupied by the micro-scaffold when it 
was still present. This condition was verified only for the short time µTP. 
 
Immunofluorescence and Multiphoton anlaysys 
Over culture time (EP1 to EP9) 1 ml of μTP suspension was collected from the 
spinner culture every two days in order to be imaged by Confocal Leica TCS SP5 II 
combined with a Multiphoton Microscope where the NIR femtosecond laser beam 
was derived from a tunable compact mode-locked titanium:sapphire laser 
(Chamaleon Compact OPO-Vis ,Coherent). μ-TPs were ﬁxed with 4% 
paraformaldehyde for 20 min at room temperature, rinsed twice with PBS buffer, and 
incubated with PBS-BSA 0.5% to block unspeciﬁc binding. After fixation, the samples 
were stained with phalloidin tetramethylrhodamine B isothiocyanate (phalloidin, 
Sigma-Aldrich) and SYTOX Green (Invitrogen), for actin microﬁlaments and nucleus 
detections, respectively. In particular the samples were incubated with SYTOX Green 
stock solution (10 mg/mL in dimethyl sulfoxide) diluted in PBS (1/500 v/v) for 10 min 
at 37°C, and after rinsing in PBS, they were stained with phalloidin for 30 min at room 
temperature. Moreover two-photon excited fluorescence has been used to induce 
second harmonic generation (SHG) and obtain high-resolution images of unstained 
collagen structures in μ-TPs’ ECM. The samples were observed under the 
simultaneous excitation of the three different lasers: λex =488 nm, λem = 500-530 
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nm for cell nuclei; λex = 543 nm, λem=560-650nm for cell cytoskeleton) and λex = 
840nm (two photons), λem =415-425 under for unstained collagen detection 
generated by Second Harmonic Generation (SHG). Other samples where stained to 
detect specific cardiac markers (α- actinin sarcomeric and Cx43 gap junction). The 
immunofluorescences were performed on sample slices 5-8 μm thick obtained by 
cryomicrotome (Leica CM 1850). Anti-α actinin sarcomeric monoclonal antibody was 
used at dilution 1:800 (Sigma); Anti-Cx43 polyclonal antibody was used at dilution 
1:2000 (Sigma). The secondary antibodies for α-actinin sarcomeric and Cx43 were: 
Alexa Fluor 488 mouse anti-mouse IgG (H+L) (dilution 1:500; Life technologies) , 
Alexa Fluor 546 mouse anti-rabbit IgG (H+L) (dilution 1:500; life technologies). 
Finally, the sample slices were imaged under Confocal Leica TCS SP5 with: λex 
=488 nm, λem = 500-530 nm for α-actinin sarcomeric; λex = 543 nm, λem=560-
650nm for Cx43. 
 
Ultrastructural analysys (TEM) 
TEM was performed to observe cells and the typical functional structure of cardiac 
tissue. μ-TPs were ﬁxed with 2.5% glutaraldehyde (Sigma-Aldrich) in sodium 
cacodylate buffer 0.1 M (pH 7.2), washed with sodium cacodylate buffer and then 
ﬁxed with 1% aqueous osmium tetroxide (Electron microscopy sciences, USA). 
Afterwards, the samples were dehydrated in a graded series of ethanol (Sigma-
Aldrich), block contrasted with 1% uranyl acetate (Merck, Germany) and embedded 
in EMbed 812 (Electron microscopy sciences, USA). The prepared ultra-thin sections 
(65 nm) were contrasted with 0.3% lead citrate (Merck, Germany) and imaged with a 
Philips CM12 transmission electron microscope at an accelerating voltage of 80 kV. 
 
Self assembly: spontaneous aggregation of μ-tissues  
At time point EP3, a small amount of micro-tissues were collected from the spinner 
and placed in a round bottom multiwell low attachment (Corning Costar Ultra-Low 
Attachment Multiwell Plates 96 well) in order to promote their fusion. Images from the 
multiwell were taken every other day up to 11 days. From the images was evaluated 
the total area of the micro-tissues and reports as ration of the area between total 
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area at EP (t) and EP3 (where t varied from t = 1, to t = 11 days). 
 
μ-tissue self beating measurements 
The investigation of spontaneously beating of μ-TPs was carried out by placing a 
small amount of micro-tissue collected from the spinner in a Petri low attachment 
placed under an inverted microscope (OLYMPUS - X81), coupled with a CMOS-
camera (Hamamatsu Photonics – C11440-22CU). The beating micro-tissues were 
imaged at 30 fps. The movies were inspected both visually and by image processing 
tool. For visual inspection, the number of beating was counted and divided by the 
movie duration time (approximately 35 sec) and converted in beat per minutes. The 
image analysis was performed by measuring the change of micro-tissue morphology 
along the time. To obtain the change of morphology as function of time the image 
sequences were analyzed with Stack Differences plug in Image J (NIH, version 
1.43m). The peaks of the curves obtained corresponded to a single beat.  
 
Self assembly and synchronization: Membrane depolarization measurements 
For analysis of electrical communication we used a membrane voltage sensitive, di-
4-ANEPPS (molecular probes), to monitor the action potential propagation and the 
electrical connection between the μ-TPs. Di-4-ANEPPS stock solution (2mM) was 
freshly prepared with DMSO (sigma) solution and added to the culture medium to 
give a final concentration of 10μM of D-4-ANEPPS. The samples were exposed to 
the dye at 37°C for 30 min, the samples were then washed in Tyroide’s solution 
consisting (in mM) 140 NaCl, 4 Cl, 0.5 MgCl2, 1.8 CaCl2, 5 HEPES, 55 D-glucose(PH 
7.4). We recorded the samples by Confocal Leica TCS SP5 II and the signals were 
monitored through a high resolution by Leica TCS SP5 Confocal microscope 
(70ms/frame, pixel size 713.7nm, objective HCX IRAPO L 25X/0.95 water immersion, 
resonant scanner 8000Hz, pinhole 600µm). Fluorescence ratio imaging 
measurements are typically performed by recording fluorescence intensities excited 
at about 450 and 510 nm, detecting emission at >570 nm. The ratio of these 
intensities (F450/F510) decreases upon membrane hyperpolarization. 
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External stimuli responsiveness 
μ-TP were equilibrated in 1x Tyrode’s solution at 37°C for 1 hour prior to 
measurement. Electrical responses of μ-TPs were assessed using custom made 
testing chambers. μ-TP were paced between a pair of graphite electrodes kept 1 cm 
apart by a silicon bracket glued to a glass slide. Using this device made in laboratory 
we collected the μ-TP among the electrodes were placed with Tyrode’s solution, 
which was enough to partially submerge the electrodes. The small chamber volume 
ensured that most of the μ-TP was located between the electrodes.  A signal 
generator (Thurlby Thandar Instruments, TGA 1230) connected to the electrodes 
provided the desired electrical stimulation (Pulse features: Ampl. : 4.5V/cm, Freq. : 
1Hz / 0.5Hz). Contractions and response to external stimuli of μ-modules were 
recorded with a CMOS-camera (HAMAMATSU PHOTONICS – C11440-22CU) on an 
Inverted microscope (OLYMPUS - X81) with an acquisition of 30 fps. The image 
sequences were analyzed using ImageJ (NIH, version 1.43m). The contractility of μ-
TP was defined as the fractional en face area change during one contraction cycle 
using frame-by-frame video analysis in ImageJ. 
 
3.3 Results and discussion 
3.3.1 Micro-scaffold production and characterization 
The morphology of GPMs is shown in figure 2 (A, B). The modified double emulsion 
technique allows the fabrication of micro particles having good sphericity, high 
superficial and bulk porosity with a high degree of interconnection. The average pore 
size was about 20 μm and the microspheres diameters distribution falls in the range 
of 75-150 μm. As described above, the GPMs were prepared in two formulations by 
varying their crosslink degree, 2% and 5% respectively. We showed [2] the higher 
the crosslink extent, the higher the degradation time. Lastly, the number of dry micro-
carries per milligram was evaluated to be 5000 beads per milligram by video-
microscopy analysis.  This was done in order to control the cell/microspheres ratio at 
the inoculums step of the seeding phase, as described below. 
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Figure 2: GPM morphology by SEM micrographs. 
 
3.3.2 Cardiac-μTP evolution and characterization  
Cell adhesion and proliferation: viability and morphology of Cardiac-μTP  
As explained in chapter 2, the cardiac function is determined by the coordinated and 
dynamic interaction of several cell types together with components of the 
extracellular matrix (ECM). This interaction is regulated by mechanical, chemical, and 
electrical signals between the cellular and non-cellular components of the heart. 
Recent studies using fluorescence-activated cell sorting indicate that the number of 
myocytes remains relatively constant during development and disease, whereas the 
number of fibroblasts and other cell types can change dramatically. Cardiac 
fibroblasts appear to have different origins at different stages of development and 
fluctuate in response to a variety of physiological signals. Fibroblasts form a network 
of cells that are connected to each other via specific cadherins and connexins, to the 
ECM via integrins, and to myocytes by a variety of receptors, including connexins 
Quantitative changes in mechanical, chemical, and electrical signals can alter the 
overall cardiac form and function [4]. In the heart, the cellular components primarily 
consist of myocytes, fibroblasts, and the vascular system. In addition, transient cells, 
such as mast cells, macrophages, and lymphocytes, can be found under certain 
conditions, such as in response to pathophysiological stimuli (Fig. 3). Finally, in 
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cultures with more NMCs, the cardiomyocytes may have slower beating rates, less 
negative membrane potential, and slower action potential upstroke velocities [24,25]. 
 
 
 
 
FIGURE 3: Model of interactions between cells and extracellular matrix in the heart. 
 
 
 
 
 
Seeding Phase (SP) 
Seeding phase parameters were optimized by inoculating CM-R and porous gelatine 
micro-spheres at the ratio of 1000 cells*bead−1 in a spinner flask. Cell adhesion and 
distribution on gelatine micro-spheres, was strongly related to dynamic culture 
parameters. The MMT images in figure 4, show that cell cell-to-bead distribution and 
cell seeding efficiency, were improved by using the dynamic condition “b” (5 min 
stirring at 30 rpm and 30 min resting up to three days) compared with dynamic 
condition “a” (5 min stirring at 30 rpm and 30 min resting for six h followed by 
continuous stirring at 30 rpm up to three days).  
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FIGURE 4: MTT on μ-TP after 3 days of culture, 4A: condition “a”. 4B: condition “b” showed the increased 
cell seeding efficiency. 
 
 
 
Evolution Phase (EP)  
The evolution phase was carried out by using three different formulations with 
cardiac cells: CM-R (+), CM-R (-) and CM-ER. In figure 5 the results of Alamar blue 
assay are shown and a comparison between CM-R (+) and CM-R (-) was made in 
terms of the number of cells per micro-beads during culture time. For both micro-
muscle types the cell number increased with culture time. During the first 3 days of 
culture the cell number was quite similar (600 cell / beads, figure 5), but, as culture 
time increased, the micro-tissue created with CM-R (-) showed an hyper proliferation 
of cells compared with C-MR (+). This was due to the effect of BrDu addition that 
hinders fibroblast proliferation. The cell population named CM-ER, did not proliferate 
over culture time due to the high cardiomyocytes content (data not shown) according 
to literature data [26,27]. 
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Figure 5: Alamar blue assay showed that During the first 3 days of culture the cell number was quite 
similar (600 cell / beads, figure 5), but, as culture time increased, the micro-tissue created with CM-R (-) 
showed an hyper proliferation of cells compared with C-MR(+). This was due to the effect of BrDu addition 
that hinders fibroblast proliferation. 
 
 
Histology 
Histological analysis in Figure 6 shown the morphological difference of the micro-
tissues realized with the three kind of cell population at time point EP3 and EP9. CM-
ERs were no not able to colonize the micro-scaffold and they shown to grow and to 
aggregate around the scaffold (figure 6 A). As the culture time increased the cells 
was able to form spherical clusters resembling a cardiac spheroids made-up mainly 
by cell aggregate (figure 6B). CM-R (-)s shown a good integration with micro-scaffold 
just after the seeding phase. Indeed, figure 6C (time point EP3) shows that cells are 
embedded within the micro scaffold and a small amount of extracellular matrix has 
been produced. At the time EP9 the scaffold was completely disappeared and the 
micro-muscle is mainly composed by extracellular matrix. Moreover the centre of 
micro-muscle was observed to be quite necrotic (figure 6D). By using CM-R (+) cells 
it was observed a similar behaviour as CM-R (-) at the time point EP3 (figure 6E). 
Interestingly, at time point EP9 the micro-muscle shown a better morphology in terms 
of cell distribution and ECM synthesis and no necrotic core was observed (Figure 
6F).  
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Figure 6: Hematoxylin and eosin staining images of cardiac μ-TP. Images showed the time evolution of 
μTP in terms of cells number increase, the ability to colonize the pores of the GMP and cell-seeded GPM 
aggregate formation. Scale bar is 100μm. 
 
 
 
 
In summary, we showed that morphological and functional cardiac μ-TP 
characteristics are different, depending on the presence or absence of proliferating 
NMCs. As described above, the number of cardiac fibroblasts appears to be crucial 
in the evolution and function of the heart tissue. Whether similar cell interactions 
occur in vivo, for example pathological states were frequently associated with 
myocardial remodelling involving fibrosis. This was observed in ischemic and 
rheumatic heart disease, inflammation, hypertrophy, and infarction. The growth in 
fibrous tissue content was based on the maintained proliferative potential of 
fibroblasts, and the synthesis of extra-cellular matrix (ECM) proteins, predominantly 
by fibroblasts [6,7].  
 
Immunofluorescence and Multiphoton analysis 
For the following investigation only data concerning to CM-R (+)-μTPs are presented 
because it was considered the gold standard formulation. Spatial distribution of cells 
and ECM within the CM-R(+)-μTPs has been analyzed by means of multichannel 
fluorescence and multiphoton imaging (figure 7 A,C), as well as polarized microscopy 
images from PRS stained μTP sections (figure 7 B,D). The images refer to “short 
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time” (EP3-EP5) and “long time” (EP6-EP9) of spinner culture. The multichannel 
images highlight cell’s nuclei in green, cell’s cytoskeleton in red, unstained collagen 
in gray. In the polarized images the de-novo synthesized collagen is shown in a 
colour scale ranging from green to red. The images showed the time evolution of 
μTPs in terms of number of cells, collagen deposition, μTPs aggregation and 
degradation of micro-scaffold. At short time of culture (figure 7A) the cells are mainly 
present on the surfaces of the GPM and colonize a small fraction of the inner pores; 
no signal of mature collagen was detected by SHG. At “long time” (Fig.7C) the μTPs 
morphology changed, the GPM porosity appeared collapsed and it was impossible to 
distinguish individual GPM. The number of cells increased with culture time and 
some neo-ECM deposition was observed (gray).  
As explained in section 2.5 (Properties and Functions of Cardiac Extracellular 
Matrix), the role of extracellular matrix proteins in the heart during development and 
in several pathologic situations has received considerable attention in recent years. 
Recently developed biochemical and morphologic methodologies have revealed that 
extracellular matrix components are important in the organization of cellular 
structures as well as in the developing heart, and were partially responsible for 
contractile function and dysfunction in healthy and diseased hearts, respectively. 
Furthermore, in figure 7 B, D the PRS staining allowed monitoring collagen 
maturation and evolution with time. According to histology and SHG images, from 
short time culture to long time culture there is an increase in collagen deposition (red 
and green pixel) but it is interestingly to highlight that the proportion of green fibers 
decrease while the proportion of red fibers increases (Figure 7 E,F).   
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Figure 7: time evolution of morphology and ECM composition 
 
 
Ultrastructural analysis (TEM) 
TEM micrographs demonstrated that from the fourth day onwards the cardiac-μTPs 
showed development of typical functional structures of cardiac tissue (Figure 8). 
Ultrastructural hallmarks of cardiomyocyte were the development of T tubules with 
sarcoplasmic reticulum, specialized cell-cell junctions as an intercalanted disk and 
desmosomes. Moreover in figure 8D the cell well stretched on micro-scaffold was 
observed and in Figure 8E the transmission electron micrographs of the constructs 
demonstrated the presence of well-organized myofilaments with equally spaced Z 
lines.  
 
 
Figure 8: TEM micrograph of μTP showed development of typical functional structures of cardiac tissue   
after 4 days of culture. A) Intercalanted disk, arrow B) Glycogen, C) Desmosomes , arrow D) the cell 
stretch on micro-beads and tuble t  with the sarcoplasmic reticulum (SR), arrow E) Well-organized 
myofilaments with clearly defined Z-lines (arrow). 
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Self assembly: spontaneous aggregation of μ-tissues 
Cardiac μ-tissue precursors obtained by previous steps were collected in a low 
attachment multiwell and the ability of biological fusion was studied by image 
analysis. In the graph (Fig. 9) it was possible to observe a reduction in μm2 in the 
time of the micro-tissues.  
 
 
 
Figure 9: Reduction in μm2 in the time of the micro-tissues. 
 
 
Time evolution of functional properties 
At first day of evolution phase (EP1) spontaneous beating was recorded. The beating 
rate, evaluated by ImageJ (figure 10 A,B) analysis, revealed a decrease in the 
beating activity of μTPs from short time (20 b.p.m) to long time (12 b.p.m)  as shown 
in figure 10 C. This observation was confirmed by further analysis: the expression of 
Cx-43 [5]. In fact the beating properties are believed to be related to GJ 
communications and finally linked to expression of Cx-43. In figure 10 D,E 
immunofluorescence images showing the distribution of α-actinin sarcomeric (green) 
and Cx-43 (red) during culture time are reported. Cardiomyocytes were tightly 
60 
 
interconnected with gap junctions and pulsate simultaneously in native heart tissue 
[9]. It is also well-known that confluent cultured cardiomyocytes on culture surfaces 
connect via gap junctions and beat simultaneously. Therefore whether electrical and 
morphological communications were established between μTPs was a crucial point. 
In fact, we examined by immunofluorescent analysis whether GJ communication was 
established between the μTPs during a “short” and “long time”. Figure 10 shows the 
monoclonal antibody against Cx43-specific peptides revealed distinct punctuate 
staining at myocyte cell-cell contacts. The number and size of Cx43-positive spots 
decreased with the culture period, at "short time" abundant Cx43 was detected not 
only at cell-to-cell interfaces, but also on the free cell membrane, while at "long time" 
there were a small number of Cx43-positive spots at the zones of contact between 
myocytes and the size of each spot was also small. Finally, by means of image 
analysis it was possible to extrapolate the time evolution of the Cx-43 density 
expressed as pixel / mm2, shown in figure 10, indicating a decrease of junction 
density in the tissue with culture time.  
These results demonstrated that the cardiac micro-tissues during the “short time” 
preserve intact Cx43 on their surfaces. These results suggest that, in the time that 
coincides with “short time”, the capability of self aggregation with a  rapid and intact 
GJ formation in addition to deposited the right amount ECM, provide a functional 
communication between μTPs, creating a cardiac micro modules equipped with self-
beating and synchronization. Instead, the “long time” micro-modules could be 
considered pathological μTP; decrease in the beating and cx-43 is probably due to 
the increase in the cardiac fibroblasts and the factors they produce.  
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Figure 10: Expression of Cx43 between μTPs during “short” and “long time”. The constructs were fixed 
and the frozen sections were obtained. The frozen sections stained with anti-Cx43 antibody (red) and α-
actinin sarcomeric (green) revealed that Cx43 was abundant during the “short time” not only at cell-to-
cell interfaces, but also on the free cell membrane, while in the "long time" the quantity of cx-43 
decreases dramatically. The graph showed the morphometrical analysis of Cx43-positive spots during 
“short” and “long time”.  
 
 
Self-Assembly and synchronization: Membrane depolarization measurements  
The conduction and propagation of action potential within and between the μTPs was 
critical for successful cardiac tissue engineering. Biological communication between 
the μTPs, was proved by use of voltage sensitive probes in order to evaluate time 
evolution of fluorescence directly linked to the membrane depolarization. The 
depolarization rate in localized areas in the μTPs was compared with their global 
beating rate marked as “a”, “b”, “c” and “global”, respectively (figure 11 A,B). By 
reporting the variation of the fluorescence intensity with the time (figure 11 C-F), it is 
possible to see that there is signal synchronization within and between the μTPs. 
Indeed, the beating frequency evaluated in all points was similar (30 b.p.m.) and the 
values are very close those one evaluated by means of bright field imaging.  
Of particular importance was the ability to assess local differences in contractility and 
whether action potentials propagated throughout the thickness of the construct or 
merely on the surface. This data demonstrates the ability of cells to migrate into the 
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porous micro-scaffold, not remaining on the surface, and the skill to communicate 
with each other generating the synchronizing of the beat. It was found that three days 
were necessary to establish a sufficient electrical connection between the μTPs 
without any conduction disturbance. Thus, we thought that these analyses would 
provide important basic data for the transplantation of myocardial μTPs in future 
studies. 
 
 
Figure 11: Image analysis performed on the same samples, in bright field and with voltage sensitive 
probes, demonstrated that there is synchronized spontaneous beating. We compared the beating of three 
different zones in the micro-tissue: a, b, c with a beating of the global micro-tissue.  
 
 
Electrical response assessment 
A certain amount of the μTPs contracted spontaneously in the absence of external 
electrical stimulation. Other than such active properties, the passive beating was 
investigated by placing non-beating μTPs under pulsating electrical stimulations by 
means of the device described above and showed in figure 12 A.  Two train pulse 
signals having different frequency were imposed: 1Hz and 0.5Hz respectively. By 
recording the shape change by bright field images of the μTPs, it was possible to 
establish that μTPs contract with the same frequency (figure 12 B,C). 
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Figure 12: A) Device made in lab to stimulate the micro-tissue. B) The graphs show the response at the 
different frequency stimuli. 
 
 
3.4 Conclusions 
The in vitro fabrication of dense native heart-like tissue holds great promise not only 
for myocardial infarction treatment but also as an in vitro experimental model for the 
study. Due to limited cell migration in 3D preformed scaffold and restriction of nutrient 
transportation, traditional top down scaffolds-based approach had not proven to be 
suitable for the fabrication of dense engineered heart tissues, unless external 
stimulation and bioreactor are used. Other techniques, such as scaffold free tissue 
engineering or cell laden microgel, even if lead to the realization of functional cardiac 
muscles does not allow the development of a cardiac ECM and are formed mainly by 
cell aggregates that because of correctly arranged give rise to macroscopic functions 
such self-beating.   
Here we focused on the possibility to build-up a functional cardiac micro-muscle 
where the ECM growth and assembly is taken in to account. It has been used the 
gelatine because cell are able attaches and migrates, and is thus suitable for 
cultivating the adherent cells. Moreover it has been demonstrated that the interaction 
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between pore surface and fibroblasts lead to a deposition of endogenous ECM in the 
pore space [5,28]. This study demonstrates the feasibility of forming dense CTE 
grafts in vitro by means of porous gelatine composite micro-beads, exploiting to main 
advantages:  
 The small size of the micro-beads facilitates rapid transport of nutrients by 
diffusion to cells at any location in the beads. Indeed using the correct cell 
composition the micro-tissues are viable up to nine days of culture.  
 Characterizing sub-millimeter sized micro-tissues containing cardiomyocytes 
and cardiac fibroblasts cells we found that fibroblast interacting with gelatine micro-
scaffold was able to lid down ECM entrapping cardiomyoocytes, generating a tissue 
equivalent formed by cell embedded in their own ECM.  
It has been demonstrated that to do this, cellular composition and choice should be 
optimized. We demonstrated that cardiac micro-tissues containing intact GJ 
precursors in addition to deposited ECM allow for rapid and complete electrical 
communications. Finally, characterizing the individual μTP and we found that there 
are able to self assemble and by exploiting such properties we realized a 3D cardiac 
patch as described in the next chapter. 
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CHAPTER 4 
 
3D CARDIC-TISSUE EQUIVALENT IN VITRO 
 
4.1 Introduction  
One of the most challenging issues of cell-based tissue engineering is the 
implementation of strategies to successfully culture large construct in vitro mimicking 
the natural tissue organization. To reach this aim recent efforts have been 
concentrated on bottom-up tissue fabrication methods [6] using both scaffold-free 
[7,8] and scaffold-based micro-modules as building blocks [9,10] to generate a larger 
3D tissue construct. However, while many studies focused their attention on the 
molding capability of building blocks [8,9,11,12], at best of our knowledge few efforts 
have been spent to reach a deep understanding of their role in ECM organization as 
well as the cellular organization. To address this challenge cells have been mixed 
with natural or artificial hydrogel or seeded on micro-carriers to form modular tissues 
of specific geometries and mechanical properties. In this context, cell-laden hydrogel 
resembled the architecture of the target tissue at micron-scale, but scaling up the 
production to tissue level dimensions has not been proven yet [6,9]. On the contrary, 
a long time culture of 3D engineered tissue rich in endogenous ECM have been 
performed by molding cell-seeded micro-beads [12,10]. This kind of scaffold-based 
building block have the ability to temporarily support the new tissue, giving the 
possibility to the cells to organize and in order to be provided by cell-derived ECM 
layer essential for the cells to grow and differentiate in a tissue like environment, 
biologically fused in a 3D tissue equivalent under appropriate culture conditions. In 
this fashion, our has developed [13] a  strategy yielding 3D cardiac tissue constructs 
of defined size and geometry by means of the biological sintering of cell seeded 
micro-scaffold so-called micro-tissue precursors (μTPs). Since μTPs were shown to 
spontaneously aggregate in a stable manner, a 3D viable tissue formation strategy 
based on the assembly of μTPs was proved feasible (Chapter 3). Furthermore, we 
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assessed that the optimal time and dynamic process conditions optimized in order to 
promote and to control the cellular organization and the assembly of de novo 
deposited ECM lead to the realization of a 3D cardiac equivalent. 
In this chapter the optimal time for taking the μTPs for aggregation in 3D tissue 
equivalent and the role of micro-scaffold properties in providing guidance to direct 
tissue morphogenesis has been investigated. Engineered constructs then were 
compared to native cardiac tissue to assess their suitability to serve as an in vitro 
model for scientific studies and potentially as tissue equivalents for in vivo tissue 
repair. 
 
4.2 Materials and methods  
4.2.1 Cardiac-TP molding  
As previously described [1] cardiac-μTPs suspension was transferred from the 
spinner ﬂask, to a 50 ml Falcon centrifuge tube and, after settling, transferred by 
pipetting into the maturation chamber to allow their molding in disc-shaped construct 
(1 mm in thickness, 5 mm in diameter). After 3 days in spinner flask it was collected 
the μTP into the chamber maturation. During the filling procedure, the maturation 
chamber was accommodated on a device connected with a vacuum pump to make 
the process faster and to assure that any bubble was in the maturation space. Finally 
the assembling chamber was placed on the bottom of a spinner ﬂask and completely 
surrounded by culture medium. The spinner was operated at 60 rpm and the medium 
was exchanged every 2 days. The maturation space was disk shaped (1 mm in 
thickness, 1 mm in diameter) inserted in a dynamic environment allowing tangential 
flow that guarantee optimal nutrient supply and waste removal through the 
maturation space during the culture time. After 7 days in the assembling chamber 
obtained a 3D cardiac tissue equivalent. 
 
 4.2.2 Self-beating 
The 3D cardiac tissue after 7 days into maturation chamber was characterized of 
self- beating. The investigation of spontaneously beating of μ-TP was undertaken 
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using a CMOS-camera (hamamatsu photonics – C11440-22CU) on an inverted 
microscope (OLYMPUS - X81).  
 
4.2.3 Cell and ECM organization 
Cell and ECM organization along the biohybrid’s thickness were assessed by 
performing histological analysis on transverse sections of biohybrid. Transverse 
sections of samples were stained using hematoxylin-eosin (Bio Optica solutions, 
Masson’s trichrome (Sigma Aldrich) and Picro Sirius Red (PSR) (Sigma Aldrich) 
following standard procedure and analyzed by an optical microscope (BX53; 
Olympus). Moreover histological sections from neonatal ventricle rat stained with the 
same histological staining were observed and compared. Polarized light images of 
samples stained with PSR alone were acquired with an inverted microscope (BX53; 
Olympus) with a digital camera (Olympus DP 21). A linear polarizer was placed 
between the light source and the specimen, while the analyzer was installed in the 
light path between the specimen and the camera. It was known that the color of 
collagen ﬁbers stained with PSR and viewed with polarized light depends upon ﬁber 
thickness; as ﬁber thickness increases, the color changes from green to red [14,15]. 
 
4.3 Results and discussion 
4.3.1 Self-beating 
To realize a 3D macroscopic cardiac-like tissue, it was choose to use as building 
block μTPs-CM-R(+) in the short time phase (EP-4) because their major functional 
properties. To do this, μTPs were loaded in a micro pipette and casted in the 
maturation chamber that was then placed in a spinner flask bioreactor to guarantee 
dynamic culture conditions. The Assembly process was stopped after 7 days 
obtaining a 3D cardiac-like tissue 5 mm in diameter and 1 mm thick. The beating 
frequency of the patch was evaluated by means of video-microscopy (see 
supplementary info patch.avi) and it was evaluated a beating frequency of 
approximately 150 b.p.m. Moreover, we interpret these data to reflect a “conditioning” 
effect: greater initial CM number promote CM survival, in fact CM-CM interactions 
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may also be important. It has been reported that the MCs release into the culture 
medium complex proteins that promote their own survival and beating [23]. It was 
therefore possible that MCs condition their microenvironment in culture and that a 
great number of NMCs somehow interfere with this process, perhaps by degradation 
or binding of a macromolecule necessary for MC communication. However, a great 
beat showed that the biological fusion was complete into 3D and that with this strategy 
cardiac cells retain the ability to communicate between them. 
 
4.3.2 Histology  
Figure 1 shows the morphological analyses performed on cross section of cardiac 
patch and comparison with native cardiac muscle from neonatal rat is also reported. 
Figure 1 A, D shows Masson Trichrome staining of cardiac patch and native tissue, 
respectively. From the images it is possible to see that collagen (in blue) was present 
in small amounts, along the whole thickness and was distributed between the cells as 
well as in native tissue. Images of H/E histology of the cross section of biohybrid 
(Figure 1 B) shown complexes of multicellular aggregates and longitudinally oriented 
cell bundles as in the native tissue (Fig.1 E). Moreover, by PRS analyses, Fig 1C and 
1F, it is possible to observe a network of fibrillar collagen filling the interstitial space 
and bridging the gap between the cells and the porous gelatine scaffold.  
Mechanical stress plays an important role in the regulation of myocardial structure 
and function, a process well recognized by cardiac surgeons [16]. Increased 
mechanical stress can stimulate cells to hypertrophy, orient, and increase their 
contractile state [17,18,19]. Increased mechanical load can also stimulate the 
secretion and reorganization of extracellular matrix components [20]. The 
extracellular matrix was the substrate for cell adhesion, growth, and differentiation, 
and it provided the mechanical support necessary for effective cardiac contraction 
[21,22]. Given the critical role of mechanical stimuli in maintaining effective 
myocardial structure and function, the goal of this study was that without any 
mechanical stimulation there was a balanced cell proliferation, without necrotic areas, 
and highly organized formation of the fibrillar collagen network that results with an 
organization of tissue in which cells and ECM were not arranged randomly but there 
is an orientation along an axis. 
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Figure 1: Histological analyses. A, D) Masson trichrome stained cross section of cardiac patch and 
neonatal ventricle rat, respectively. B, E) Hemtoxylin and eosin staining of cardiac tissue equivalent and 
neonatal tissue, respectively. C, F) PRS staining on cardiac patch made in lab and neonatal tissue, 
respectively. Scale bar is 100μm. 
 
4.4 Conclusions  
In this study we have demonstrated that modular cardiac tissues could be used to 
produce a 3D cardiac tissue equivalent. The matrix scaffold provided a transient but 
crucial structural support for the cells until they can secrete and maintain their own 
extracellular matrix.  In order to obtain a macroscopic viable 3D tissue equivalent we 
needed firstly to engineer the μTPs in terms of their ECM composition. Cardiac cells 
were able to adhere and to growth on micro-scaffold and by means of cell / material 
cross talk, the key components of the ECM were secreted and assembled. Such 
process leads to an up-regulation of the ECM assembly on the TPs in suspension, 
leading to the death of the TPs. Indeed, as spinner culture increased we observed 
that even if the fibroblast growth was blocked, the mature fraction increased. At the 
early time (short time culture) of the spinner culture, the immature fraction of the 
cardiac ECM was higher and we used such micro tissues as building block for the 
realization of the 3D cardiac muscle. After one week of assembly and maturation we 
observed a tissue characterized by an increased self-beating and the ECM was quite 
similar to that one of the native tissues. We observed that this behavior was the 
opposite of the micro-tissue evolution where the cells were engaged in assembly the 
existing ECM, leading to a formation of a scar-like tissue. In the assembly phase it 
seems that cells were preferentially engaged in leading down new ECM in order to 
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reach a configuration characterized by a completely connected and synchronized 3D 
structure. The development of a functional tissue construct was dependent on the 
capacity of the seeded cells to re-establish an architecture that resembles native 
myocardium. Our observations indicate that with this approach, the heart cells 
possess an innate capacity to re-establish complex 3D myocardial organization if 
provided with appropriate environmental cues. 
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